| Literature DB >> 35761408 |
Roberta Giansante1, Chiara Palka Bayard De Volo2, Melissa Alfonsi2, Elisena Morizio3, Paolo Guanciali Franchi3,2.
Abstract
BACKGROUND: Small supernumerary marker chromosomes (sSMC) are additional centric chromosome fragments too small to be identified by banding cytogenetics alone. A sSMC can originate from any chromosome and it is estimated that 70% of sSMC are de novo, while 30% are inherited. Cases of sSMC derived from chromosome 5 (sSMC5) are rare, accounting for1.4% of all reported sSMC cases. In these patients, the most common reported features are macrocephaly, dysmorphic facial features, heart defects, growth retardation, hypotonia, and intellectual disability. Also sSMC derived from chromosome 8 are very rare and the phenotype of patients with sSMC8 is very variable. Common clinical features of the patients include developmental delay, mental retardation, intellectual disability, hypotonia, hypospadias, attention deficit hyperactivity disorders (ADHD), skeletal anomalies, dysmorphic facial features, and renal dysplasia. To the best of our knowledge, in literature there are no cases with coexistence of sSMC5 and sSMC8, so we reviewed the literature to compare cases with SMC5 and those with SMC8 separately. This study is aimed to highlight the unique findings of a patient with the coexistence of sSMC5 and sSMC8. CASEEntities:
Keywords: Chromosome 5; Chromosome 8; Dysmorphic facial features; In situ hybridization; Supernumerary marker chromosome
Year: 2022 PMID: 35761408 PMCID: PMC9237997 DOI: 10.1186/s13039-022-00601-5
Source DB: PubMed Journal: Mol Cytogenet ISSN: 1755-8166 Impact factor: 1.904
Fig. 1Array-CGH chromosome 5
Fig. 2Array-CGH chromosome 8
Fig. 3Karyotype 48, XX, +mar1 dn, +mar2 dn.ish r(5)(p13.2q11.2)(wcp5+), r(8)(8p11.21q11.21)(wcp8+).arr[GRCh37] 5p14.2p14.1(23,788,614–25,320,290)×3,5p13.2p11-5q11.1q11.2(36,967,000–52,194,364)×3,8p11.21p11.1-8q11.1q11.21(39,963,778–48,649,507)×3
Genetic and clinical features of cases with sSMC 5
| Avansino et al. [ | Stankiewicz et al. (case 1) [ | D’Amato Sizonenko et al. (case 1) [ | D’Amato Sizonenko et al. | Sarri et al. [ | Loscalzo et al. [ | Melo et al. [ | Hadzsiev et al. [ | Camerota et al. [ | Armstrong et al. [ | Present case | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SMC5 coordinates | 5p10 p13.1 | 5p14 q11.2 | 5p10 p13.3 | 5p13.3q12.3 | 5p13q11.2 | 5p11 p13.3 | 5p11q12.1 | 5p14 q11.1 | 5p13 q12.2 | 5p13.3 q11.2 | 5p13 q11.2 | |
| Karyotype | 47 XY+mar | 47,XX,+r/46,XX | 47,XX+r/46,XX | 47,XY+r/46,XY | 47 XX,+r/46,XX | 46,XX,dup(5) | 47 XX,+r/46,XX | 47 XX,+mar | 47 XX+r/46 XX | 47 XY,+mar | 48, XX,+mar1,+mar | |
| Age at evaluation | 5 months | 7 y | 3 y | 9 months | 9 y | 5 y | 4 y | 10 y | 17 y | 18 y | 1 months | |
| Gestational age | 31 weeks | NR | 37 weeks | 37 weeks | 37 weeks | 33 weeks | NR | At term | At term | 30 weeks | 30 weeks | |
| Developmental delay | + | NR | + | + | − | + | + | + | − | + | + | 8/11 |
| Intellectual disability | NR | + | + | − | + | NR | + | + | − | + | + | 7/11 |
| Congenital heart defect | + | − | − | − | + | + | − | − | − | − | + | 4/11 |
| Respiratory issues | + | − | + | + | − | + | − | − | − | + | + | 6/11 |
| Macrocephaly | + | NR | + | + | + | + | NR | + | + | + | + | 9/11 |
| Upslanted palpebral fissures | + | + | + | + | − | + | NR | − | + | − | + | 7/11 |
| Hypertelorism | + | + | + | + | + | + | + | + | + | − | + | 10/11 |
| Midface hypoplasia | + | − | + | + | − | − | NR | + | − | + | + | 6/11 |
| Depressed nasal bridge | + | + | + | + | − | + | − | + | + | − | + | 8/11 |
Fig. 4Schematic representations of sSMC5 size of 11 cases present in literature
Genetic and clinical features of cases with sSMC8
| Allen and Hodgkin [ | Biennow et al. [ | Digilio et al. pz 1 [ | Digilio et al. pz 2 [ | Melnyk and Dewald [ | Ohashi et al. [ | Butler et al. [ | Spinner et al. [ | Rothernmund et al. II-1 | Rothernmund et al. III-1 | Rothenmund et al. III-2 [ | Present case | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (a) | |||||||||||||
| sSMC coordinates | 8p21-pter | centromeric | Isodicentric 8p;8p | Isodicentric 8p;8p | 8p11.2-q11.2 | (8p23.1-pter) | pericentric | Pericentric p11-q11 | pericentric | pericentric | pericentric | 8p11.21q11.21 | |
| Karyotype | 46 XX -11+der (11)t(8;11) (p21q25) | 46 XX /47XX+mar | 46XX/46XX-8+idic(8) (qter-p23) | 46XX/46XX-8+idic(8) (qter-p23) | 47 XX+mar | 47 XX+mar | 47 XY+mar | 47 XY+mar | 46 XY (90) /47XY+mar (10) | 47 XX+mar | 47 XX+mar | 48, XX,+mar1,+mar2 | |
| Age at evaluation | At birth | 1 year | 14 months | 2 months | 15 months | 2 years | At birth | 7 months | 30 years | 4 years | XX at birth | XX, 21 months | |
| Gestational age | 34 weeks | 39 weeks | 28 weeks | At term | At term | 35 weeks | At term | At term | / | At term | At term | 30 weeks | |
| Developmental delay | − | − | − | + | + | + | − | + | − | + | + | + | 11/19 |
| Intellectual disability | + | + | + | + | + | − | + | + | − | + | + | + | 16/19 |
| Congenital heart defect | + | − | + | + | − | + | − | − | − | − | + | + | 7/19 |
| Respiratory issues | − | − | + | − | − | + | − | − | − | + | − | + | 6/19 |
| Macrocephaly | + | − | − | − | − | − | − | + | − | − | − | + | 5/19 |
| Upslanted palpebral fissures | − | − | − | + | + | − | − | − | − | − | − | + | 4/19 |
| Hypertelorism | + | + | − | + | − | − | − | − | − | − | − | + | 5/19 |
| Midface hypoplasia | − | − | − | − | − | − | − | − | − | − | − | + | 1/19 |
| Depressed nasal bridge | − | − | + | + | + | − | − | − | − | − | − | + | 5/19 |